TY - JOUR
T1 - Cost-effectiveness of myocardial perfusion imaging
T2 - A summary of the currently available literature
AU - Des Prez, Roger D.
AU - Shaw, Leslee J.
AU - Gillespie, Robert L.
AU - Jaber, Wael A.
AU - Noble, Gavin L.
AU - Soman, Prem
AU - Wolinsky, David G.
AU - Williams, Kim A.
N1 - Funding Information:
Dr Shaw has grant support from Fujisawa Healthcare, GE-Amersham, and BMS- Medical Imaging. Dr Williams has grant support from Astellas, GE-Amersham, BMS-Medical Imaging, CV Therapeutics, and King Pharmaceuticals.
PY - 2005/11/1
Y1 - 2005/11/1
N2 - In summary, evidence is convincing that, for the intermediate-risk patient, initial investigation with SPECT studies is a cost-efficient approach. In special populations including emergency-department (ED) patients, diabetic patients, and women, there is additional information indicating the cost effectiveness of SPECT. For low-risk patients, cost-effective strategy appears to be stress ECG, with the selective use of SPECT for a patient whose initial test is abnormal. For high-risk patients, cardiac catheterization is in most analyses found to be the most effective diagnostic approach. However, some believe that initial SPECT studies are nevertheless indicated even in stable patients with a high probability of coronary disease because these studies can provide additional data to help direct the most effective use of revascularization therapy.
AB - In summary, evidence is convincing that, for the intermediate-risk patient, initial investigation with SPECT studies is a cost-efficient approach. In special populations including emergency-department (ED) patients, diabetic patients, and women, there is additional information indicating the cost effectiveness of SPECT. For low-risk patients, cost-effective strategy appears to be stress ECG, with the selective use of SPECT for a patient whose initial test is abnormal. For high-risk patients, cardiac catheterization is in most analyses found to be the most effective diagnostic approach. However, some believe that initial SPECT studies are nevertheless indicated even in stable patients with a high probability of coronary disease because these studies can provide additional data to help direct the most effective use of revascularization therapy.
UR - http://www.scopus.com/inward/record.url?scp=29844455240&partnerID=8YFLogxK
U2 - 10.1016/j.nuclcard.2005.10.001
DO - 10.1016/j.nuclcard.2005.10.001
M3 - Article
C2 - 16344238
AN - SCOPUS:29844455240
SN - 1071-3581
VL - 12
SP - 750
EP - 759
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
IS - 6
ER -